首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral Agents
【2h】

Identification of Protein-Protein Interaction Inhibitors Targeting Vaccinia Virus Processivity Factor for Development of Antiviral Agents

机译:靶向痘苗病毒加工性因子的蛋白-蛋白质相互作用抑制剂的鉴定用于开发抗病毒药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poxvirus uracil DNA glycosylase D4 in association with A20 and the catalytic subunit of DNA polymerase forms the processive polymerase complex. The binding of D4 and A20 is essential for processive polymerase activity. Using an AlphaScreen assay, we identified compounds that inhibit protein-protein interactions between D4 and A20. Effective interaction inhibitors exhibited both antiviral activity and binding to D4. These results suggest that novel antiviral agents that target the protein-protein interactions between D4 and A20 can be developed for the treatment of infections with poxviruses, including smallpox.
机译:痘病毒尿嘧啶DNA糖基化酶D4与A20和DNA聚合酶的催化亚基结合形成了过程性聚合酶复合物。 D4和A20的结合对于进行性聚合酶活性至关重要。使用AlphaScreen分析,我们确定了可抑制D4与A20之间蛋白质相互作用的化合物。有效的相互作用抑制剂表现出抗病毒活性和与D4的结合。这些结果表明,可以开发针对D4和A20之间蛋白质-蛋白质相互作用的新型抗病毒药,以治疗包括天花在内的痘病毒感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号